Phage-displayed random peptide libraries in mice: toxicity after serial panning. 2002

David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
Department of Surgery, College of Medicine and the Vermont Comprehensive Cancer Center, Given Bldg Rm E309, Burlington, VT 05405, USA. David.Krag@uvm.edu

OBJECTIVE In vivo screening of phage-displayed random peptide libraries (RPLs) has been used to identify peptide ligands to targets found on endothelial cells of blood vessels supplying specific tissues such as brain, kidney, and tumor tissue. Peptides that bind specifically to blood vessels supplying tumor tissue have been conjugated to cytotoxic agents and used to successfully eradicate tumors in a mouse model. With the ultimate goal of developing similar methods for treating human cancer, we describe an in vivo RPL screening process that, unlike previous in vivo experiments, does not harm the animal being screened. METHODS RPLs were administered to FVB, BalbC, and tumor-bearing MRL/MpJ-fas(LPR) mice in a variety of dosing formats. Tumor nodules were excised 10 min following infusion and phage were amplified from the specimens. Phage were reinjected into the same animal within 48 h. This process was repeated twice for a total of three in vivo screens of mouse tumor tissue within the same animal. Mice were observed for systemic side effects, histopathologic damage, and presence of phage in organs. Peptide sequences were determined from several third-pan phage clones. RESULTS Overall there was minimal toxicity from administration of single or repeat doses of RPLs. Amino acid consensus sequences were identified and some of the sequences were similar to those of peptide ligands that bind matrix metalloproteinases. CONCLUSIONS Serial administration of an RPL is well tolerated and serial panning in individual mice leading to consensus sequence motifs is possible. Based on these preclinical data the Food and Drug Administration has approved the implementation of human clinical trials with this technique.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D003090 Coliphages Viruses whose host is Escherichia coli. Escherichia coli Phages,Coliphage,Escherichia coli Phage,Phage, Escherichia coli,Phages, Escherichia coli
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
March 2009, Journal of virological methods,
David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
January 1995, Methods in enzymology,
David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
February 1999, Combinatorial chemistry & high throughput screening,
David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
August 1998, Current opinion in biotechnology,
David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
April 1995, Gene,
David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
May 2005, Environment international,
David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
October 1996, Molecular diversity,
David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
January 1996, Methods in molecular biology (Clifton, N.J.),
David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
July 2001, Methods (San Diego, Calif.),
David N Krag, and Susan P Fuller, and Lyn Oligino, and Stephanie C Pero, and Donald L Weaver, and Amy L Soden, and Christopher Hebert, and Sadie Mills, and Chen Liu, and Daniel Peterson
February 2011, Molecules (Basel, Switzerland),
Copied contents to your clipboard!